Rafael Holdings, Inc. (AMEX:RFL) was founded in 2017 and is headquartered in Newark, New Jersey, USA, with 18 full-time employees. It is a clinical stage biopharmaceutical company and holds commercial property rights.
Rafael Holdings, Inc. (RFL):
Rafael Holdings, through its subsidiaries, is committed to the development and commercialization of therapies that use the metabolic differences between normal cells and cancer cells to treat tumors. Rafael Holdings, Inc. operates through two divisions, Real Estate Holdings and Pharmaceuticals (subdivided into Rafael Pharmaceuticals, Inc. and Lipomedix Pharmaceuticals Ltd.).
In addition to the Pharmaceuticals division engaged in the pharmaceutical business, Rafael Controls also holds commercial real estate assets through Real Estate Holdings, including a 20-story office building and attached garage in Newark, New Jersey, with a total area of approximately 496,000 square feet and approximately 800 parking spaces; A 3-story office/data center property in Piscataway, New Jersey, with a total area of approximately 65,000 square feet; and a 12,400 square-foot property in Jerusalem, Israel, with tenants including IDT, etc.